Multiple sclerosis patients less likely to get cancer; Blood test may predict dangerously tiny babies; Olmesartan linked to severe gastrointestinal problems

(June 22, 2012 - Insidermedicine)

From BC - Multiple sclerosis patients are at reduced risk of cancer, according to a report published in Brain. Comparing MS patients in BC to the general population, researchers found that those with the neurological condition had a reduced risk of developing cancer, and that their risk of colorectal cancer was significantly lower.

From Ottawa - Research published in the Journal of Clinical Endocrinology and Metabolism identifies a protein that may help predict which women will have dangerously small babies. Researchers studied 72 pregnant women, half who gave birth to dangerously small babies and half who had normal weight babies. They found that women with high levels of the protein IGFBP-4 in the first trimester were 22x more likely to give birth to a dangerously small baby.

From Rochester - Patients taking Olmesartan may be at increased risk of severe gastrointestinal problems, according to a report published in the Mayo Clinic Proceedings. Researchers treated 22 patients taking the blood pressure drug Olmesartan who had symptoms similar to celiac disease--chronic diarrhea, vomiting, nausea and severe weight loss--but blood tests revealed no disease. Doctors took the patients off of the drug, and all showed significant improvement in their symptoms.

nba lockout over nba lockout news nba lockout news gifts for mom gifts for mom pepper spray storage auctions